Trial Details
COMPLETEDBasic Information
| Clinical ID | c1695 |
|---|---|
| Identifier | NCT04656730 |
| Trial Title | Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome|Functional Dyspepsia |
| Interventions | DRUG: Iberogast® and Iberogast® N |
Participant Information
| Sponsor | Hospital Vall d'Hebron |
|---|---|
| City | Badalona |
| Country/Region | Spain |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2020-09-03 |
|---|---|
| Primary Completion Date | 2023-01-31 |
| Completion Date | 2023-01-31 |